ArticleParasites & vectors2025
Lysinibacillus sphaericus exposure impedes Anopheles dirus's oviposition via downregulating vitellogenin.
Article in Parasites & vectors, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Evaluation of the Insecticidal Potential ofInsects · 2025Article
- Evaluating the transstadial effects of Bacillus velezensis and pyriproxyfen, alone and in combination, on fitness-related traits of Culex quinquefasciatus.Parasites & vectors · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundVector control using Lysinibacillus sphaericus is an effective strategy for preventing the transmission of mosquito-borne diseases. Our previous study demonstrated that exposure to L. sphaericus during the larval stage of Anopheles dirus significantly reduced the fecundity of surviving adult mosquitoes. However, the underlying mechanisms driving this reduction remain unclear. Sublethal doses of L. sphaericus, often resulting from insufficient or delayed application, can still impact mosquito populations. Therefore, this study aimed to investigate how sublethal doses of L. sphaericus inhibit the reproductive capacity of An. dirus mosquitoes.
methodsFirst, the staining method was used to detect L. sphaericus in surviving adult mosquitoes that had been exposed to sublethal doses during the larval stage. Second, adult mosquitoes were fed a sucrose solution containing L. sphaericus, and the effects on the reproductive capacity were observed. Third, transcriptome sequencing and qPCR were employed to identify and validate genes associated with oviposition suppression in An. dirus following treatment with sublethal doses of L. sphaericus. Finally, we assessed the effects of sublethal doses and direct feeding of L. sphaericus on vitellogenin (Vg) expression and activation of the target of rapamycin (TOR) signaling pathway using qPCR and Western blotting.
resultsOur findings demonstrated that L. sphaericus persists in adult An. dirus mosquitoes that survived larval exposure to sublethal doses. Additionally, feeding adult female mosquitoes with L. sphaericus significantly suppressed their oviposition ability. Transcriptome analysis revealed substantial alterations in gene expression profiles among surviving mosquitoes exposed to sublethal doses of L. sphaericus. Notably, L. sphaericus inhibit lysosomal function and lipid metabolism, which are critical for mosquito physiology. Furthermore, L. sphaericus significantly downregulated the Akt-TOR signaling pathway and Vg expression in adult mosquitoes.
conclusionsExposure An. dirus larvae to L. sphaericus resulted in the persistence of L. sphaericus in surviving adult mosquitoes and significantly suppressed female oviposition by downregulating Vg expression via inhibition of lysosomal function and the TOR signaling pathway. This study offers novel insights into the interaction between L. sphaericus and its mosquito host and identifies potential molecular targets for controlling mosquito population density by modulating oviposition behavior.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.